BIOVF Dividend: Swedish Orphan Biovitrum AB (publ) Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	27,851	26,027	22,123	18,790	15,529	15,261
Revenue Growth (YoY)	10%	18%	18%	21%	2%	7%
Cost of Revenue	6,075	5,717	4,952	4,413	3,484	3,225
Gross Profit	21,776	20,310	17,171	14,377	12,045	12,036
Selling, General & Admin	-1,541	7,302	6,668	5,415	4,341	4,007
Research & Development	3,352	3,503	2,719	2,228	1,981	1,581
Operating Expenses	14,633	14,488	12,495	9,856	8,258	7,573
Other Non Operating Income (Expenses)	0	-59	-51	-28	-35	-33
Pretax Income	-699	4,407	2,954	3,321	3,295	4,217
Income Tax Expense	-704	528	546	683	616	972
Net Income	14	3,885	2,409	2,638	2,679	3,245
Net Income Growth	-100%	61%	-9%	-2%	-17%	-2%
Shares Outstanding (Diluted)	344.64	345.56	325.96	312.45	310.72	311.6
Shares Change (YoY)	-1%	6%	4%	1%	0%	6%
EPS (Diluted)	0.04	11.24	7.39	8.44	8.62	10.41
EPS Growth	-100%	52%	-12%	-2%	-17%	-7%
Free Cash Flow	4,209	4,383	-473	3,099	5,100	1,074
Free Cash Flow Per Share	12.21	12.68	-1.45	9.91	16.41	3.44
Gross Margin	78.18%	78.03%	77.61%	76.51%	77.56%	78.86%
Operating Margin	25.64%	22.36%	21.13%	24.06%	24.38%	29.24%
Profit Margin	0.05%	14.92%	10.88%	14.03%	17.25%	21.26%
Free Cash Flow Margin	15.11%	16.84%	-2.13%	16.49%	32.84%	7.03%
EBITDA	17,287	9,513	7,794	6,767	5,753	6,450
EBITDA Margin	62.06%	36.55%	35.23%	36.01%	37.04%	42.26%
D&A For EBITDA	10,144	3,691	3,118	2,246	1,966	1,987
EBIT	7,143	5,822	4,676	4,521	3,787	4,463
EBIT Margin	25.64%	22.36%	21.13%	24.06%	24.38%	29.24%
Effective Tax Rate	100.71%	11.98%	18.48%	20.56%	18.69%	23.04%

Swedish Orphan Biovitrum AB (publ) (BIOVF) Price